8-K
filed May 5, 2026, 7:59 PM ET
ticker KKR
CIK 0001404912
earnings
confidence low
sentiment positive
materiality 0.50
KKR Q1 2026: ~20% YoY growth cited for FRE, TOE, and Adj. NI; details limited
KKR & Co. Inc.
- Fee Related Earnings, Total Operating Earnings, and Adjusted Net Income per share each grew approximately 20% year-over-year in Q1 2026.
- Monetization activity accelerated during the quarter; KKR invested more capital over the past 12 months than at any prior point.
- Company celebrated its 50th anniversary on May 1, 2026; management expressed high confidence in its platform and long-term positioning.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001404912-26-000011
- form_type
- 8-K
- ticker
- KKR
- cik
- 0001404912
- company_name
- KKR & Co. Inc.
- filed_at
- 2026-05-05T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:32.243020+00:00
- generated_at
- 2026-05-14T23:19:39.804471+00:00
- sec_items
- ["2.02", "9.01"]
- event_type
- earnings
- sentiment
- positive
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- low
- secwatch_canonical_url
- https://secwatch.observer/filing/0001404912-26-000011
- json_url
- https://secwatch.observer/filing/0001404912-26-000011.json
- markdown_url
- https://secwatch.observer/filing/0001404912-26-000011.md
- text_url
- https://secwatch.observer/filing/0001404912-26-000011.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1404912/000140491226000011/0001404912-26-000011-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1404912/000140491226000011/kkr-20260505.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
IVF
INVO Fertility FY2025 revenue $6.84M (+5% YoY); net loss improves to $(5.3)M
INVO Fertility, Inc.
June 2, 2026, 8:40 AM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
and technologies,
today announced fiscal year 2025 financial results. FY2025
Financial Highlights (all metrics compared to FY2024 unless otherwise noted) ● Revenue
was $6,841,250, an increase of 5% compared to $6,532,000. ● Consolidated
clinic revenue increased 4% to $6,721,057, compared to $6,450,431. ● Revenue
from all clinics was $8,021,929, including
Filing page
SEC filing
POLA
Polar Power Q1 net loss narrows 86% to $178K; gross margin expands to 65.7%
Polar Power, Inc.
June 2, 2026, 8:30 AM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
Q1 2026 Q1 2025 Y/Y +/(-) Change Net sales $ 1,728 $ 1,723 — Gross profit $ 1,135 $ 320 255 % Gross margin 65.7 % 18.6 % 47.1 pts Total operating expenses $ 1,111 $ 1,421 22 % Income (loss) from operations $ 24 $ (1,101 ) 102 % Net loss $ (178 ) $ (1,265 ) 86 % Net loss per share $ (0.05 ) $ (0.50 ) 90 %
Filing page
SEC filing
EXPI
eXp World Holdings Q1 revenue $1.0B (+5% YoY), net loss narrows to $(5.1M), Adj. EBITDA $4.1M (+88%)
eXp World Holdings, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
the company's scale and our focus on operational efficiency across eXp World Holdings,” said Jesse Hill, Chief Financial Officer of eXp World Holdings. “We generated revenue of $1.0 billion and Adjusted EBITDA of $4.1 million, an 88% improvement that further strengthened our financial position. More recently, we executed the strategic NextHome acquisition using cash
Filing page
SEC filing
HAIN
Hain Celestial reports Q3 FY2026 earnings; detailed figures not included in filing excerpt
HAIN CELESTIAL GROUP INC
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
On May 11, 2026, The Hain Celestial Group, Inc. (the “Company”) issued a press release announcing financial results for its third quarter ended March 31, 2026.
Filing page
SEC filing
HRTX
Heron Q1 net revenue $34.7M (-10.8% YoY); Acute Care up 32%; guidance reaffirmed
HERON THERAPEUTICS, INC. /DE/
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
Reaffirms Guidance - Q1 2026 net revenue growth year-over year for Acute Care franchise (+32%), including ZYNRELEF ® (+27%) and APONVIE ® (+50%) - Q1 2026 total net revenue of $34.7 million - Reached settlement with Baxter Healthcare Corporation in CINVANTI ® patent litigation - Reaffirmed 2026 full-year guidance of $173–$183 million net revenue; $10–$20 million
Filing page
SEC filing
XGN
Exagen Q1 2026: Record revenue $17.3M, net loss $4.0M; FY guidance reaffirmed
EXAGEN INC.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
Trailing-twelve-month average selling price (ASP) $ 444 $ 419 Cash and cash equivalents $ 21,513 $ 11,194 First Quarter 2026 Highlights: • Achieved record total revenue of $17.3 million, an increase of 12% compared to first quarter 2025. • Grew AVISE CTD test volume 10% compared to first quarter 2025. • Expanded AVISE CTD trailing-twelve-month ASP to $444 per
Filing page
SEC filing
CGBD
Carlyle Secured Lending Q1 NII $0.36/sh; NAV down 2.3% to $15.89; declares $0.35 dividend
Carlyle Secured Lending, Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 7.01, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
For the first quarter of 2026, we reported $0.36 per common share of Net Investment Income and Adjusted Net Investment Income, a non-GAAP financial measure described below.
Filing page
SEC filing
OPAL
OPAL Fuels Q1 2026 Adj EBITDA $16.7M, net loss $(5.6)M; revenue down 14% YoY
OPAL Fuels Inc.
May 11, 2026, 7:59 PM ET
earnings
Items 2.02, 9.01
same fact type: earnings_release
same SEC item: 2.02, 9.01
same event type: earnings
similar materiality
This filing
On May 5, 2026, KKR & Co. Inc. issued an earnings release announcing its financial results for the quarter ended March 31, 2026.
Comparable filing
Revenue for the three months ended March 31, 2026 and 2025, was $73.4 million and $85.4 million respectively, a decrease of (14)%, compared to the same period last year. 1 • Net (loss) income for the three months ended March 31, 2026 was $(5.6) million, compared to $1.3 million in the same period last year. • Basic and diluted net loss per share attributable to Class A common shareholders for the three months ended months ended March 31, 2026 were $(0.09) compared to $(0.01) in the comparable period last year.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.